APA (7th ed.) Citation

Li Wang, Kegang Jia, Fang Li, Chenxu Zhang, Gang Feng, & Jun Du. (2021). Comparison of Improvement in 2-Year Survival Rate of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Different Durations of Chinese Patent Medicine: A Retrospective Cohort Study. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Li Wang, Kegang Jia, Fang Li, Chenxu Zhang, Gang Feng, and Jun Du. Comparison of Improvement in 2-Year Survival Rate of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Different Durations of Chinese Patent Medicine: A Retrospective Cohort Study. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Li Wang, et al. Comparison of Improvement in 2-Year Survival Rate of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Different Durations of Chinese Patent Medicine: A Retrospective Cohort Study. Frontiers Media S.A., 2021.